AI summary Trust: medium Third-party lab

This COA was tested by an independent third-party lab, LabE. The tirzepatide batch (Mfgr: April 1, 2025) showed 99.35% purity via HPLC. However, the tested quantity was significantly lower than labeled, at 23.8mg against a 30mg label, a deviation of -20.7%. Endotoxin status is not applicable, and the test is older (6-12 months).

Watch out for
  • significant quantity deviation (-20.7%)
  • older (6-12 months)
  • no endotoxin test
Test date
2025-07-02
Purity
99.35% 99.35%
Batch / lot
[NAME_REDACTED]: April 1, 2025
Lab
LabE
Quantity
label 30mg tested 23.8mg
Qty vs label
-20.7%
Endotoxins
n/a
Test score
5.7
Manufacturer
Oupeptide
View vendor dossier
Certificate

Test report image

Certificate scan
Certificate scan as published.
Source

Finnrick

✓ Artifact captured

We have the certificate image (SHA-256 hash captured) — you can verify it loads from the upstream lab and matches the artifact below.

Verify on upstream
Method
HPLC + mass quantification + endotoxins
Test type
finnrick_composite
Dose
30mg
Container
No Label / Silver Crimp / Black Cap
Catalogued
2026-04-16
Artifact hash
a865d5d84766d793…
This COA is part of TitrateLab's community-trust corpus. See more from Oupeptide or learn how trust scores are computed on the methodology page.